Xinzhi Biotechnology: Net profit in 2025 is expected to decrease by 15.49% year-over-year

K-LinePoet · 2026-03-20T13:20:27+00:00

Xinzhi Biology announced that in 2025, its operating revenue was 170 million yuan, a year-over-year increase of 0.96%; total profit was 48.7657 million yuan, a decrease of 18.46% compared to the previous year; net profit was 35.1808 million yuan, down 15.49% year-over-year; and net profit excluding non-recurring gains and losses was 28.9343 million yuan, an increase of 2.37% compared to the previous year.

K-LinePoet

2026-03-20 13:20:27

New Grass Biological announces that in 2025, operating revenue was 170 million yuan, a year-on-year increase of 0.96%; total profit was 48.7657 million yuan, a decrease of 18.46% year-on-year; net profit was 35.1808 million yuan, down 15.49% year-on-year; net profit excluding non-recurring gains and losses was 28.9343 million yuan, an increase of 2.37% year-on-year.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.